Conference item
A brain metastasis therapy tweak, for the better? Concomitant stereotactic radiotherapy and molecular-targeted therapy
- Abstract:
-
The most common cause of cancer demise is the metastasis to distant organs. In particular, brain metastasis represents one of the highest mortality rates in the oncology field. Some of the reasons for the meagre advance in the treatment of this disease are the limited conditions for favourable surgical debulking of tumour, off-target effects of conventional treatments and the limited efficacy of delivery into the brain for currently available drugs. Contrary to those conventional strategies, ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 212.0KB)
-
- Publisher copy:
- 10.1093/neuonc/now292.008
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- 2016 British Neuro-Oncology Society Meeting (BNOS 2016) Journal website
- Volume:
- 19
- Pages:
- 126
- Host title:
- Neuro-Oncology
- Publication date:
- 2017-03-02
- Acceptance date:
- 2016-06-27
- DOI:
- EISSN:
-
1523-5866
- ISSN:
-
1522-8517
- Source identifiers:
-
719630
Item Description
- Pubs id:
-
pubs:719630
- UUID:
-
uuid:41a21992-b867-4671-a907-3a77bdc09c9c
- Local pid:
- pubs:719630
- Deposit date:
- 2018-10-30
Terms of use
- Copyright holder:
- Soto et al
- Copyright date:
- 2017
- Notes:
- © The Author(s) 2017. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. This abstract was presented at the 2016 British Neuro-Oncology Society Meeting (BNOS 2016). This is the accepted manuscript version of the abstract. The final version is available online from Oxford University Press at: https://doi.org/10.1093/neuonc/now292.008
If you are the owner of this record, you can report an update to it here: Report update to this record